期刊
MOLECULAR CELL
卷 82, 期 7, 页码 1288-+出版社
CELL PRESS
DOI: 10.1016/j.molcel.2022.03.011
关键词
-
资金
- Swiss National Science Foundation (SNF) [179323]
- SNF R'Equip [177084]
- Austrian Science Fund (FWF) [28975]
- Human Frontiers Research Project (HFSP) long-term fellowship [LT000121/2019-L]
- EMBO Scientific Exchange Grant
This study reveals the structural features and activation mechanism of neurofibromin, providing important insights into disease-causing mutations and cancer susceptibility. The findings suggest a role for nucleotides in the regulation of neurofibromin, and may lead to new therapeutic approaches for modulating the Ras signaling pathway.
Mutations in the NF1 gene cause the familial genetic disease neurofibromatosis type I, as well as predisposition to cancer. The NF1 gene product, neurofibromin, is a GTPase-activating protein and acts as a tumor suppressor by negatively regulating the small GTPase, Ras. However, structural insights into neurofibromin activation remain incompletely defined. Here, we provide cryoelectron microscopy (cryo-EM) structures that reveal an extended neurofibromin homodimer in two functional states: an auto-inhibited state with occluded Ras-binding site and an asymmetric open state with an exposed Ras-binding site. Mechanistically, the transition to the active conformation is stimulated by nucleotide binding, which releases a lock that tethers the catalytic domain to an extended helical repeat scaffold in the occluded state. Structure-guided mutational analysis supports functional relevance of allosteric control. Disease-causing mutations are mapped and primarily impact neurofibromin stability. Our findings suggest a role for nucleotides in neurofibromin regulation and may lead to therapeutic modulation of Ras signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据